Fibroblast collagenase (MMP-1), a member of the matrix metalloproteinases family, is believed to be a pathogenesis of arthritis, by cleaving triple-helical type II collagen in cartilage. From the similarity of the active site zinc binding mode with hydroxamate, we designed and synthesized a a-mercaptocarbonyl possessing compounds (3-5), which incorporated various peptide sequences as enzyme recognition sites. The P 4 -P 1 peptide incorporating compound (3) exhibited as potent inhibition as the hydroxamate (1) and the carboxylate (2) type inhibitors, with an IC 50 of 10 ؊6 M order against MMP-1. But the inhibitor (3) related compounds (6-8) displayed decreased or no inhibitory potencies. These results suggest that the existence of both the carbonyl and thiol groups might be critical for the inhibition, and the distance between the two functional groups is important for inhibitory potency. For P n peptide incorporating compounds (4a-k), except for 4h and 4k, all compounds showed IC 50 values under sub-nanomolar. Among them, for potent inhibition, Leu was better than Phe and Val as the P 1 amino acid, and the P 2 position amino acid was necessary, and preferentially Phe. Insertion of the P n peptide into 4d or 4k, giving compounds 5a-c, did not increase the activities of 4d and 4k. Substitution of the mercapto group with other functional groups lost the activity of compound 4a. The stereochemical preference at the thiol-attached position was also determined by preparation of both isomers of 4a. It was found that the S configuration compound (36b) is approximately 100 times more potent than the corresponding R-isomer (36a).
Matrix metalloproteinases (MMPs) are zinc endometallopeptidases that are involved in the degradation and remodeling of connective tissues. This family of enzymes shows proteolytic activity towards virtually all of the constituents of the extracellular matrix. The members of this family, currently numbering 20, can be classified into four groups, which are: the collagenases that cleave triple-helical interstitial collagen; the gelatinases that cleave denatured collagen, elastin, and type IV and V collagen; the stromelysins that mainly cleave proteoglycans; and the membrane-type MMPs that have a C-terminal transmembrane domain for anchoring to the cell membrane. The MMPs are involved in crucial physiological and physiopathological events, such as wound healing, nerve growth, angiogenesis, and pregnancy. In these physiological processes, MMP activity is tightly regulated. [1] [2] [3] [4] [5] However, excessive MMP synthesis and release can lead to connective tissue degradation and destruction, which occurs in tumor invasion, metastasis, 6) corneal ulceration, 7) arthritis, 8a) periodontal disease, 9) and multiple sclerosis. 10) A number of MMP inhibitors have progressed into clinical trials mainly for cancer and rheumatoid arthritis. In the structures of those MMPs inhibitors, a hydroxamate group is utilized as a zinc-chelating group (ZCG) predominantly because of its superior zinc-chelating potency. Previously, we explored MMP-1 inhibitors that had a hydroxamate group (1) 11) and a carboxylate group (2). 12) These compounds contain a P 4 -P 1 peptide sequence and exhibited inhibitory activity for MMP-1 in the order of 10 Ϫ6 M for IC 50 (Fig. 1 ). Our objective is to explore the usefulness of novel ZCGs as inhibitors of MMPs, and in particular of MMP-1. A further aim is to compare the MMP-1 inhibitory potencies of compounds that incorporate various enzyme recognition moieties.
Mercapto groups are good ZCGs, as found in Captopril, which is a well-known angiotensin converting enzyme (ACE) inhibitor. In this study, we explored mercapto group based compounds that incorporated various peptide sequences as enzyme recognition functionalities.
Design The X-ray crystal structures of MMP-1 with bound inhibitors reveal that the hydroxamate acts as a bidentate ligand with each oxygen at an optimal distance (2.1-2.2 Å) from the active-site zinc ion (structure A, Fig. 2 ). 13) From this structural analysis data, we reasoned that the amercaptocarbonyl group (structure B) at the cleavage site would chelate at the active-site zinc ion by both carbonyl and mercapto groups in a similar manner as the hydroxamate (Fig. 2 ). In comparison with the hydroxamate possessing MMPs inhibitors, little is known about thiol group including compounds. But, previously Donald and colleagues developed a b-mercapto carbonyl group possessing compound that exhibited 10 Ϫ7 M order of IC 50 against MMP-1. 14) The compound differs in the distance between the carbonyl and mercapto groups from the structure B. In addition, Baxter and colleagues have prepared the thiol containing inhibitors utilizing computer-aided drug design, expecting new interactions with MMP-8 by hydrogen bonds, e.g. Ser172 of MMP-8. 15) These compounds exhibited potent inhibitions with an IC 50 of 10
Ϫ7

-10
Ϫ9 M against MMP-3, -8, -9, but were not tested on MMP-1. We designed three different compounds containing an a-mercaptocarbonyl group, based on the enzyme recognition sites. The P 4 -P 1 peptide incorporating compound (3), the P 1 Ј-P 2 Ј peptide incorporating compound (4), and both P n and P n Ј peptides incorporating compound (5) were designed. Also we designed three different thiol compounds based on (3) to confirm the necessity of the carbonyl group and the propriety of the distance between the carbonyl and thiol group: one lacking the carbonyl group (6); insertion of a methylene spacer between the carbonyl and the mercapto group (7) ; and replacement of the carbonyl by a hydroxy group (8).
To verify the usefulness of the a-mercaptocarbonyl group for MMP-1 inhibitory potency, substitutions of the mercapto group with other functional groups (alkylsulfanyl, alkylsulfinyl, alkyldisulfanyl, hydroxyl, amino, carboxyl, or hydroxamate) were conducted and compared with the mercapto group substituted compound against MMP-1 inhibitory potencies.
Synthesis The preparations of P n peptide possessing compounds (3, 6-8) are summarized in Chart 1. The key intermediates (12) , (16) , (19) and (21) were prepared from Ntert-butyloxycarbonyl alanine (Boc-Ala-OH) (9) . A mixed anhydride, which was prepared from the reaction of 9 with ethyl chloroformate (ClCO 2 Et)/Et 3 N, was reacted with excess diazomethane to give a diazomethyl ketone (10) . This was converted to the bromomethyl ketone (11) by reaction with HBr in ether. 16) The acetylsulfanylmethylketone (12) was obtained by reaction of 11 with potassium thioacetate followed by purification by silica gel column chromatography.
The deoxygenated compound of 12 depicted as 16 was synthesized as follows. The aldehyde (14) , obtained via the aminoalcohol (13) 17) from 9, was treated with the ylide derived from potassium bis(trimethylsilyl)amide [[(CH 3 ) 3 Si] 2 NK] and methyltriphenylphosphonium bromide (CH 3 PPh 3 Br), to give the olefin (15) . 18) Then an addition of thioacetic acid to compound 15 was carried out under ultraviolet light catalyzed conditions 19) to afford 16. The acetylsulfanylethylketone (19) that differed from intermediate (12) by the distance between the carbonyl and mercapto groups, was prepared via the a,b-unsaturated compound (18) . 20) Thus the aminoaldehyde (14) was transformed into the vinyl alcohol (17) , which on Swern oxidation gave the corresponding a,b-unsaturated ketone (18) . Compound 19 was obtained by an 1,4-addition of thioacetic acid to 18. 21) The alcohol derivative (21) was prepared by an epoxide ring opening with thioacetic acid.
group. Finally, hydrolysis of the thioester (23a-d) gave the free thiol compounds (3, 6-8).
P n Ј peptide incorporating compounds 4a-k were synthesized by the route shown in Chart 2. The 3-amino-2-hydroxypropanoic acid (DL-isoserine), which was prepared from 2-aminoethanol by Nishizawa and Saino 23) was a suitable precursor for the construction of an a-mercaptocarbonyl moiety, and the amino group was a good scaffold for the P n peptide sequence. The amino group in isoserine was protected by a Boc group, followed by condensation with various dipeptides or amino acid N-methylamides (25a-k) using EDC/HOBt as a coupling reagent. Replacement of the hydroxy group with an acetylsulfanyl group (27a-k) was achieved via a mesylate intermediate. The free thiol (4a-k) was obtained by an alkaline hydrolysis according to a standard procedure. The physicochemical properties of 26a-k, 27a-k, and 4a-k are shown in Tables 1-6 .
Syntheses of both P n and P n Ј peptides possessing compounds (5a-c) are summarized in Chart 3. The N-Boc group of compounds 27d and 27k were removed by treatment with 4 N HCl in EtOAc followed by condensation with N-tert-butyloxycarbonyl-prolyl-leucine (Boc-Pro-Leu-OH, 28a) or N-tert-butyloxycarbonyl-leucine (Boc-Leu-OH, 28b) using a mixed anhydride procedure (ClCO 2 i-Bu/NEM) Chart 2. Syntheses of the P 1 Ј-P 2 Ј Peptide Incorporating Compounds to give the compounds (29a-c). The free thiol groups (5a-c) were also obtained by an alkaline hydrolysis.
Preparation of the single isomers of 4a described as compounds 36a, b are shown in Chart 4 and were achieved by utilizing chiral isoserines (32a, b) reported by Maeda et al. 24) Formation of the 2-oxooxazolidine isomers (31a, b) were conducted by the treatment of malic acid half esters (30a, b) 25) with diphenylphosphoryl azide (DPPA) and Et 3 N. Alkaline hydrolysis of the 2-oxooxazolidine (31a, b) was followed by protection of the amino group by treating with ditert-butyl dicarbonate giving N-protected isoserine (33a, b). After condensations of the isoserine (33a, b) with leucyl-Omethyl-tyrosine-N-methylamide (H-Leu-Tyr(Me)-NHMe, 25a) utilizing EDC/HOBt as a coupling reagent, subsequent conversions of the hydroxy group to the mercapto group were carried out by the same method as that described in the preparation of 4a.
The preparations of compounds where the mercapto group was replaced with other functional groups are summarized in Chart 5. The alkylsulfanyl compounds (37a-c) were obtained by the same method described in the conversion of 26 to 27 utilizing the corresponding potassium salt of alkylmercaptane instead of potassium thioacetate. Sequentially, 37a-c were oxidized by treatment with equimolar amounts of MCPBA to give the sulfoxides (38a-c). The unsymmetrical disulfide (39) was synthesized from 4a using diethyl N-ethylsulfenylhydrazodicarboxylate.
26) The amino compound (41) was also prepared via the mesylate followed by treating with sodium azide, and a hydrogenation.
27) The malonyl compound 44 was synthesized from the 3-tert-butyloxycarbonylamino-2(R,S)-benzyloxycarbonylpropanoic acid (42), 28) which was coupled to H-Leu-Tyr(Me)-NHMe (25a) using EDC/HOBt followed by catalytic hydrogenation in the presence of palladium on charcoal to give the malonyl compound (44). We also prepared the hydroxamate compound 46, which was constructed by the condensation of 44 and O-benzylhydroxylamine using EDC/HOBt as the coupling reagent and subsequent removal of the benzyl group by means of a catalytic hydrogenation.
Results and Discussion
P n Peptide Incorporating Compounds As expected, compound 3 exhibited strong MMP-1 inhibitory activity (3.5 mM IC 50 ), as potent as the hydroxamate (1) and the carboxylate (2) . But modified compounds (6) and (7) were two magnitudes less potent than 3 (530 and 220 mM IC 50 , respectively). The alcohol compound (8) had no inhibitory potency (0% inhibition at 10 Ϫ3 M). These results clearly suggest that the existence of both the carbonyl and the thiol groups might be critical for the MMP-1 inhibition, and the distance between the two functional groups is important for inhibitory potency. We aimed to find new mercapto groups in the form of a-mercaptocarbonyl moiety as a ZCG, which showed no decrease in inhibitory activity, compared with the hydroxamate (1) or the carboxylate (2). P 1 -P 2 Peptide Incorporating Compounds Regarding the P 1 Ј and P 2 Ј amino acids, Van Walt reported the substrate specificity of MMP-1 by measuring the rate of hydrolysis of various synthetic oligopeptide substrates. 29) Of those studied, Leu or Met are preferred at A.A 1 Ј and the aromatic amino acids Trp or Phe are preferred at A.A 2 Ј. Based on this information, various P 1 Ј-P 2 Ј site peptides were incorporated into a-mercaptocarbonyl moiety and their MMP-1 inhibitory activities are summarized in Table 7 . Although compounds that have Val at A.A 1 Ј (4i, 4j) exhibited sub-nanomolar potencies against MMP-1, substitution of Val at A.A 2 Ј (4h) led to a loss of inhibitory potencies. The decreased affinity for MMP-1 is probably due to the repulsion induced by adjacent isopropyl groups in 4h, which makes the molecule distort. In the case of A.A 1 ЈϭPhe (4e-g), the nature of A.A 2 Ј does affect the inhibitory potencies and these compounds all showed sub-nanomolar potencies. In a limited number of these compounds, A.A 1 ЈϭLeu (4a-d) provided the best result with respect to the MMP-1 inhibitory potencies. That is, the combinations of Leu at P 1 Ј and hydrophobic amino acid residues at P 2 Ј, such as branched alkyls or an aromatic ring, showed nanomolar inhibitory potencies and these results are identical to the substrate specificity study by Van Walt and coworker 29) A comparison of compound 4 with well-explored P 1 -P 2 Ј mimic hydroxamate inhibitors, such as batimastat, 30) reveals that the preference at P 2 Ј is a little different. In succinyl hydroxamate type inhibitors, the P 2 Ј site preferred aromatic substituents to an alkyl group for in vitro activity, 5) but for the a-mercaptocarbonyl series (4), branched alkyl residues also gave rise to inhibitory potency. Deletion of the P 2 Ј site as shown for 4k abolished the MMP-1 inhibitory activity. All of these compounds (4a-k) had been prepared in a racemic form and thus 1 : 1 mixtures of diastereoisomers because we used racemic isoserine as the starting material. To determine the stereochemical preference at the thiol attached carbon, we prepared both single isomers of 4a described as 36a, b 31) starting from chiral malic acids. As a result, the S-isomer (36b) was found to be approximately 100 times more potent than the corresponding R-isomer (Table 7) . Compounds Incorporating Both P n and P n Peptides The MMP-1 inhibitory activities of compounds incorporating both P n and P n Ј peptides (5a-c) are also summarized in Table 7 . Deletion of the P 2 Ј residue described for 5c also induced a significant loss of MMP-1 inhibitory activity. This result indicated that the P 2 Ј site amino acid plays an important role in recognition for MMP-1. Compounds 5a and 5b were expected to have stronger affinity against the enzyme than 4d or 4k, which have only the P 1 Ј-P 2 Ј peptide as an enzyme recognition site. But insertion of the P n peptide into 4d or 4k led to loss of activities. By comparing the backbones of collagen substrate and inhibitors 5a-c, it was found that the b-alanine structure in the a-mercaptocarbonyl compounds is longer than the natural peptide sequence, which might introduce a gap between enzyme subsites and side chains of inhibitors 5a, b, and caused the decreasing affinity for MMP-1.
Substitution of the Mercapto Group with Other Functional Groups Using compound 4 as the basic structure, neither the hydroxy intermediate (26a) nor sulfur atom containing and relatively stable derivatives such as the alkylsulfanyl compounds (37a-c), nor the oxidized compounds (38a-c) showed inhibitory potencies (0% at 10 Ϫ6 M). The unsymmetrical disulfide of the ethyldisulfanyl compound (39) and the amino compound (41) exhibited little inhibitory potency (18 and 11% at 10 Ϫ6 M respectively). Then we introduced a carboxylate and a hydroxamate that have the potential to chelate a zinc ion. But both the carboxylate (44) and hydroxamate (46) also showed no inhibitory potencies (0% at On the basis of these facts, it is speculated that only the mercapto group incorporating compound (4) provided a sufficient three dimensional distance between the active site zinc ion and P 1 Ј-P 2 Ј subsites.
Conclusion
From the evaluation of the P 4 -P 1 peptide incorporating compounds 3, 6-8 against MMP-1 inhibitory potency, we confirmed that the a-mercaptocarbonyl moiety plays a crucial role for chelation of the zinc ion in the MMP-1 active site. For the P n Ј peptide incorporating compounds (4a-j), the a-mercaptocarbonyl unit was also effective against MMP-1 inhibition and Leu at the P 1 Ј position exhibited the best results (4a-d) by which we achieved MMP-1 inhibitory potency at the nanomolar level. This is as potent as the inhibition of batimastat. But the intrinsic good chelation property of the a-mercaptocarbonyl unit was reduced by the existence of the P n peptide in 5a, b. Syntheses of both isomers of 4a revealed that the S configuration at the thiol attached carbon was preferred for MMP-1 inhibition and only the thiol group provided a satisfactory inhibitory result. Further evaluation of the a-mercaptocarbonyl moiety will proceed against not only other MMPs but also general metalloenzymes (e.g., angiotensin converting enzyme, tissue necrosis factor-a converting enzyme, aminopeptidase, and carboxypeptidase) to investigate the selectivity for MMP-1.
Experimental
Melting points were determined on a Yanagimoto melting point apparatus without correction. Column chromatography was performed on Silica gel BW-200 (Fuji Silysia Chemical Ltd.). TLC was performed on silica gel (Kiesel-gel 1 H-NMR was recorded on a JEOL JMN-AL300 spectrometer, and chemical shifts are given in ppm (d) from tetramethylsilane (TMS), which was used as the internal standard. Mass spectra were obtained on a JEOL JMS 700 spectrometer by fast atom bombardment (FAB) ionization techniques. Optical rotations were measured in a JASCO DIP-140 apparatus.
1-Bromo-3(S)-tert-butyloxycarbonylamino-2-oxobutane (11)
A mixed anhydride [prepared from Boc-Ala-OH (8.84 g, 46.7 mmol), ethyl chloroformate (5.58 g, 51.4 mmol) and Et 3 N (7.41 ml, 51.4 mmol) as usual] in THF (150 ml) was added to an ice-cold solution of 0.47 N diazomethane in Et 2 O (150 ml, 70 mmol). Then the reaction mixture was stirred for 2 h at the same temperature, after which it was evaporated in vacuo and the residue was partitioned between EtOAc and H 2 O. The organic layer was washed successively with H 2 O, sat. aq. NaHCO 3 , and sat. aq. NaCl, and then was dried over 
1-Acetylsulfanyl-3(S)-tert-butyloxycarbonylamino-2-oxobutane (12)
Potassium thioacetate (90% min, 97.2 mg, 0.767 mmol) was added to a solution of 11 (200 mg, 0.693 mmol) in anhydrous acetone (15 ml), after which the mixture was stirred for 30 min and then concentrated. After dilution with EtOAc and H 2 O, the organic layer was washed with H 2 O and sat. aq. NaCl. Then it was dried over MgSO 4 and concentrated to give a yellow oil, which was purified by silica gel column chromatography (eluent; n-hexane : Et 2 Oϭ 2 : 1) to give 12 as a colorless solid (164 mg, 98%). mp 65.5-69.0°C, Rf 4 0.66. 
2(S)-tert-Butyloxycarbonylamino-propanol (13)
To a solution of BocAla-OH (9) (20.0 g, 106 mmol) and N-hydroxysuccinimide (13.4 g, 112 mmol) in CH 2 Cl 2 (150 ml), EDC (24.3 g, 127 mmol) was added at Ϫ8°C, followed by stirring for 1 h at the same temperature and then at 4°C for 15 h. The reaction mixture was washed with H 2 O and sat. aq. NaCl, and then dried over MgSO 4 . The CH 2 Cl 2 solution was concentrated under reduced pressure, precipitated from 1-propanol, and collected by filtration to give an activated ester (23.3 g 77% yield). To a solution of this activated ester (23.3 g, 81.4 mmol) in THF (600 ml), NaBH 4 (8.01 g, 212 mmol) was added, followed by stirring at room temperature for 1 h. Additional NaBH 4 (4.00 g, 106 mmol) was added to the reaction mixture and stirring was continued for 1.5 h. Then the reaction mixture was poured into cold 10% aq. citric acid and the organic material was extracted with EtOAc. Next the organic layer was dried over MgSO 4 and evaporated in vacuo to give crude 13 (9.89 g, 78%) as a colorless oil. 
2(S)-tert-Butyloxycarbonylamino-propanal (14)
To a solution of oxalyl chloride (5.77 ml, 67.7 mmol) in CH 2 Cl 2 (50 ml), a solution of dimethylsulfoxide (10.6 ml, 149 mmol) in CH 2 Cl 2 (60 ml) was added dropwise at a temperature below Ϫ68°C. To the reaction mixture, a solution of the crude alcohol (13) (9.89 g, 56.4 mmol) in CH 2 Cl 2 (400 ml) was added dropwise over a period of 15 min. After stirring for 20 min at the same temperature, Et 3 N (41.4 ml, 298 mmol) was added to the mixture dropwise over a period of 30 min. Then the reaction mixture was poured into water and extracted with n-hexane. The organic layer was washed with 0.5 N aq. HCl and sat. aq.
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2(S)-tert-Butyloxycarbonylaminobut-3-ene (15)
To a suspension of methyltriphenylphosphonium bromide (6.94 g, 19.1 mmol) in anhydrous THF (50 ml), bis(trimethylsilyl)potassium amide (0.5 M solution in toluene, 38 ml, 19.0 mmol) was added dropwise at Ϫ69°C under a nitrogen atmosphere, and the mixture was stirred at the same temperature for 11 h. To this mixture, a solution of aldehyde (14) (1.57 g, 9.07 mmol) in anhydrous THF (30 ml) was added and stirred at Ϫ65°C for 15 min. Then the reaction mixture was warmed to room temperature and stirred for 1 h, after which it was stirred at 40°C for 11 h. The reaction was quenched with MeOH, after which the mixture was washed with aq. Rochelle salt solution, dried over MgSO 4 and evaporated to give a brown residue, which was purified by silica gel column chromatography (eluent; n-hexane : Et 
2(S)-tert-Butyloxycarbonylamino-3(R,S)-hydroxypent-4-ene (17)
To a solution of vinylmagnesium bromide (1.0 M in THF, 36 ml), a solution of 14 (2.00 g, 11.5 mmol) in anhydrous THF (20 ml) was added at 0°C and stirred for 2 h, followed by stirring at room temperature for 1 h. The reaction was quenched with sat. aq. ammonium chloride and the mixture was extracted with EtOAc. Then the organic layer was washed with sat. aq. NaCl, dried over MgSO 4 , and evaporated to give an oil, which was purified by silica gel column chromatography (eluent; n-hexane : EtOAcϭ4 : 1) to give 17 as a colorless oil (1.47 g, 63%). 
2(S)-tert-Butyloxycarbonylamino-3-oxopent-4-ene (18)
To a solution of oxalyl chloride (0.71 ml, 8.32 mmol) and dimethylsulfoxide (1.10 ml, 15.5 mmol) in CH 2 Cl 2 (10 ml), a solution of 17 (1.47 g, 7.30 mmol) in CH 2 Cl 2 (20 ml) was added dropwise over a period of 15 min. at Ϫ40°C, followed by stirring at Ϫ40°C for 1 h. After adding Et 3 N (5.13 ml, 36.9 mmol), stirring was continued for 6 h at room temperature and then the reaction was quenched with water. The organic layer was separated and the aqueous layer was co-extracted with CH 2 Cl 2 . Subsequently, the combined organic layer was washed with sat. aq. NaCl, dried over MgSO 4 , and then evaporated in vacuo to give a brown oil, which was purified by silica gel column chromatography (eluent; n-hexane : EtOAcϭ10 : 1) to give 18 as a colorless solid (617 mg, 42% 
1-Acetylsulfanyl-4(S)-tert-butyloxycarbonylamino-3-oxopentane (19)
To a mixture of thioacetic acid (37.3 ml, 0.527 mmol), 18 (100 mg, 0.502 mmol) and anhydrous THF (0.5 ml), tetrabutylammonium fluoride (50 mg) were added under a nitrogen atmosphere and the mixture was stirred at room temperature for 2 d. Then the reaction mixture was evaporated and purified by silica gel column chromatography (eluent; n-hexane : EtOAcϭ6 : 1) to give 19 as slightly yellow oil (80 mg, 58%). 
1(R,S)-[1(S)-tert-Butyloxycarbonylaminoethyl]oxirane (20)
To a solution of 15 (500 mg, 2.92 mmol) in CH 2 Cl 2 (25 ml), MCPBA (3.61 g, 14.6 mmol) was added and the mixture was stirred at room temperature for 1 h. Then the mixture was diluted with Et 2 O, and washed successively with cold 10% aq. Na 2 CO 3 , sat. NaHCO 3 , and sat. aq. NaCl. Subsequently, the mixture was dried over MgSO 4 , and then evaporated in vacuo to give crude 20, which was purified by silica gel column chromatography (eluent; n-hexane : Et 2 Oϭ2 : 1) to give 20 as a colorless oil (388 mg, 71% 
1-Acetylsulfanyl-3(S)-tert-butyloxycabonylamino-2(R,S)-hydroxybutane (21)
Compound 20 (649 mg, 3.47 mmol) was dissolved in thioacetic acid (2.0 ml) and stirred at room temperature for 15 h. The excess thioacetic acid was removed by evaporation, and then the residue was purified by silica gel column chromatography (eluent; n-hexane : EtOAcϭ4 : 1) to give 21 as a slightly yellow oil (293 mg, 32%). N-deprotected 12, 16, or  19) . The reaction mixture was stirred at Ϫ15°C for 1 h, and then was evaporated and the residue was purified by silica gel column chromatography (eluent; CHCl 3 : MeOHϭ40 : 1) to give 23a-c as a colorless solid.
1-Acetylsulfanyl-3(S)-(benzoyl-glycyl-prolyl-leucyl)amino-2-oxobutane (23a): Yield: 76%. 
3-tert-Butyloxycarbonylamino-2(R,S)-hydroxypropionic Acid (24)
To a solution of 2-tert-butyloxycarbonylaminoethanol (43.9 g, 272 mmol) and Et 3 N (114 ml, 817 mmol) in CH 2 Cl 2 (600 ml) cooled to Ϫ10°C, sulfur trioxide-pyridine complex (130 g, 817 mmol) in DMSO (400 ml) was added as a bolus. The mixture was stirred vigorously for 10 min at 35°C, poured into cold sat. aq. NaCl (1500 ml), and extracted with cooled Et 2 O. The organic extracts were washed with cooled 10% aq. citric acid and cooled water, dried over MgSO 4 , and then evaporated in vacuo to give the corresponding aldehyde, which was purified by silica gel column chromatography (eluent; CHCl 3 : MeOHϭ300 : 1-100 : 1) to give the aldehyde as a yellow oil (18.2 g, 42%). To a solution of the aldehyde in acetone (50 ml), an ice-cold solution of NaHSO 3 (11.9 g, 114 mmol) in water (200 ml) was added, and the mixture was stirred overnight at 5°C. To the solution of NaHSO 3 adduct, a 246
Vol. 50, No. 2 05 eq of 24) , compound 24, and DMF (4-7% w/v) at Ϫ12°C. The mixture was stirred at Ϫ3°C for 6 h and then at 0°C for 15 h. The reaction mixture was subsequently diluted with EtOAc, washed successively with sat. aq. NaCl, 1 N aq. HCl, sat. aq. NaCl, 10% aq. Na 2 CO 3 , and sat. aq. NaCl, dried over MgSO 4 , and evaporated in vacuo to give a crude product, which was purified by silica gel column chromatography (eluent; CHCl 3 : MeOHϭ 50 : 1-30 : 1) to give 26a-k as a colorless solid. Yield and spectral data for 26a-k are listed in Tables 1 and 2 .
General Procedure for the Preparation of Compounds 27a-k To a solution of 26 in CH 2 Cl 2 -pyridine (3 : 1, 4% w/v), methanesulfonyl chloride (1.5 eq of 26) was added dropwise at 0°C, and the mixture was stirred at the same temperature for 2 h. Then the reaction mixture was diluted with EtOAc (0.6% w/v) and poured into cold 1 N aq. HCl (40 eq of 26). The organic layer was washed with sat. aq. NaCl, dried over MgSO 4 , and evaporated to give a mesylate. To a solution of the mesylate in DMF (5% w/v), potassium thioacetate (5 eq of mesylate) was added, and the mixture was stirred at room temperature for 2 d. Then the reaction mixture was diluted with EtOAc, washed (4a-k, 5a-c, and 36a, b) with sat. aq. NaCl, dried over MgSO 4 , and evaporated in vacuo to give a slightly brown oil, which was purified by silica gel column chromatography (eluent; CHCl 3 : MeOHϭ60 : 1-30 : 1) to give 27a-k as a colorless solid. Yield and spectral data for 27a-k are listed in Tables 3 and 4 . General Procedure for the Preparation of Compounds 4a-k To a solution of 27 in MeOH (5% w/v), 1 N aq. NaOH (1.05 eq of 27) was added, and the mixture was stirred at room temperature for 0.5-1 h. Then the reaction mixture was diluted with EtOAc, washed successively with sat. aq. NaCl, 1 N aq. HCl, and sat. aq. NaCl, dried over MgSO 4 , and evaporated in vacuo to give a colorless residue, which was precipitated from Et 2 O to give 4a-k as a colorless solid. Yield and spectral data for 4a-k are listed in Ta 1 eq of 28a or b), and NMM (1.1 eq of 28a or b) as usual] in DMF (4% w/v) was added to an ice-cold solution of the amine hydrochloride salt (0.95 eq of 28a or b) in DMF (7% w/v). Then NMM (1 eq of amine hydrochloride salt) was added and the mixture was stirred at 0°C for 1 h. Subsequently, the reaction mixture was partitioned between EtOAc and H 2 O. The organic layer was washed successively with H 2 O, sat. aq. NaHCO 3 , and sat. aq. NaCl, dried over MgSO 4 , and evaporated in vacuo to give a crude product, which was purified by silica gel column chromatography (eluent; CHCl 3 : MeOHϭ80 : 1-40 : 1) to give 29 as a colorless solid. General Procedure for the Preparation of Compounds 5a-c To a solution of 29 in MeOH (5% w/v), 1 N aq. NaOH (1.05 eq of 29) was added and the mixture was stirred at room temperature for 0.5-1 h. Then the reaction mixture was diluted with EtOAc, washed successively with sat. aq. NaCl, 1 N aq. HCl, and sat. aq. NaCl, dried over MgSO 4 , and evaporated in vacuo to give a colorless residue, which was precipitated from EtOAc-Et 2 O to give 5a-c as a colorless solid. 02 (1H, m), 3.02-3.31 (1H, m), 3.31-3.55  (2H, m), 3.55-3.87 (3H, m), 4.05-4.21 (1H, m), 4.21-4.50 (2H, m),   4.67-4.81 (1H, m), 6.31-6.71 (1H, m), 6.99-7.33 (7H, m) 25) Trifluoroacetic anhydride (33.6 ml, 238 mmol) was added to L-malic acid (13.4 g, 99.9 mmol) and the mixture was stirred at 0°C for 2.5 h. Then the reaction mixture was concentrated using a vacuum pump while the flask was kept at 0°C. To the resulting residue, benzylalcohol (20.7 ml, 200 mmol) was added, after which the mixture was stirred at room temperature for 2 h and then diluted with EtOAc. The reaction mixture was subsequently adjusted to pH 7 by adding 10% aq. Na 2 CO 3 to give a colorless suspension, which was collected by filtration and washed with EtOAc. The sodium salt of 30a was dissolved in 1 N aq. HCl (160 ml), after which it was extracted with EtOAc, washed with sat. aq. NaCl, dried over MgSO 4 , and evaporated in vacuo to give 30a (13.3 g, 59%) as a colorless oil. Benzyl (S)-2-Oxooxazolidine-5-carboxylate (31a) 25) A mixture of 30a (4.06 g, 18.1 mmol), diphenylphosphoryl azide (4.29 ml, 19.9 mmol), Et 3 N (2.91 ml, 20.9 mmol), and benzene (60 ml) was heated under reflux for 4 h. The reaction mixture was evaporated in vacuo and the residue was dissolved in H 2 O (20 ml), which was saturated with NaCl and then extracted with EtOAc. The combined organic layer was washed with sat. aq. NaHCO 3 and sat. aq. NaCl, after which it was dried over MgSO 4 and evaporated in vacuo to leave a yellow solid, which was recrystallized from MeOH-diisopropyl ether to give 31a (2.50 g, 62%) as slightly yellow crystals. mp 132-134°C, N-tert-Butyloxycarbonyl-(S)-isoserine (33a) 25) A solution of 31a (4.65 g, 21 mmol) in 3 N aq. NaOH (61.4 ml)-MeOH (15.4 ml) was stirred at 60°C for 4 h. Then MeOH was evaporated in vacuo and washed with Et 2 O, neutralized by adding conc. HCl, and concentrated to dryness. To the residue, 1 N aq. NaOH (42 ml) and di-tert-butyl dicarbonate [4.82 g (22 mmol) in acetone (45 ml)] were added, and the mixture was stirred for 14 h at 4°C. Acetone was evaporated, after which the residue was washed with Et 2 O (2ϫ80 ml) and then adjusted to pH 2 by adding 1 N aq. HCl. The desired material was extracted with EtOAc, washed with sat. aq. NaCl, dried over MgSO 4 , and evaporated in vacuo to leave a colorless solid, which was recrystallized from EtOAc-Et 2 O to give 33a (3.42 81 (2H, m), 7.04-7.16 (2H, m), 7.18-7.40 (5H, m) 
-(tert-Butyloxycarbonylamino)-2(R,S)-(ethyldisulfanyl)propionyl]-leucyl-O-methyl-tyrosine N-Methylamide (39)
A mixture of diethyl azodicarboxylate (129 ml, 0.787 mmol), ethanethiol (56 ml, 0.75 mmol), and benzene (1.5 ml) was gently refluxed for 2 h under nitrogen atmosphere to give diethyl N-ethylsulfenylhydrazodicarboxylates 27) as a yellow solution. To the solution, a suspension of 4a (375 mg, 0.715 mmol) in benzene (5.0 ml) was added, and the mixture was stirred for 24 h at room temperature under a nitrogen atmosphere. Then the reaction mixture was evaporated to give a yellow residue, which was purified by silica gel column chromatography (eluent; CHCl 3 : MeOHϭ80 : 1) and precipitated from Et 2 O-n-hexane to give 39 as a colorless solid (78 mg, 19 %). mp 119-124°C, Rf 3 0.74. 71 mmol, derived from 26a in the same manner as that described for the preparation of 27] in DMF (17 ml), sodium azide (600 mg, 9.23 mmol) was added, and the mixture was stirred under a nitrogen atmosphere for 20 h at room temperature. The reaction mixture was diluted with EtOAc (60 ml), washed successively with sat. aq. NaCl, H 2 O, and sat. aq. NaCl, dried over MgSO 4 , and evaporated in vacuo to leave a slightly yellow solid, which was purified by flash chromatography (eluent; n-hexane : EtOAcϭ1 : 2) to give 40 (803 mg, 88%) as a colorless solid. mp 170-172°C, [ 
(R,S)-(benzyloxycarbonyl)propionyl]-leucyl-O-methyl-tyrosine N-Methylamide (43)
To a stirred solution of diisopropylamine (2.0 ml, 14.3 mmol) in THF (12 ml), 1.6 M n-BuLi in hexane (8.95 ml, 14.3 mmol) was added at Ϫ10°C under a nitrogen atmosphere. After 20 min, a solution of benzyl 3-(tert-butyloxycarbonylamino)propionate (2.00 g, 7.16 mmol) in THF (8 ml) was added dropwise over a period of 15 min at Ϫ70°C, and the mixture was stirred at the same temperature for 20 min. Then the reaction mixture (a slightly yellow solution) was poured into dry ice and diluted with 0.1 N aq. H 2 SO 4 (225 ml). The organic material was extracted with EtOAc, washed with sat. aq. NaCl, dried over MgSO 4 , and evaporated in vacuo to give crude 3-(tert-butyloxycarbonylamino)-2(R,S)-(benzyloxycarbonyl)propionic acid as a slightly yellow oil, which was used for the subsequent condensation procedure without further purification. EDC (1.51 g, 7.88 mmol) was added to a mixture of HLeu-Tyr(Me)-NHMe · EHCl (25a, 2.68 g, 7.52 mmol), Et 3 N (1.05 ml, 7.52 mmol), HOBt (1.02g, 7.52 mmol), crude 3-(tert-butyloxycarbonylamino)-2(R,S)-(benzyloxycarbonyl)propionic acid, and DMF (80 ml) at Ϫ12°C. The mixture was stirred at Ϫ3°C for 6 h and then at 0°C for 15 h. The reaction mixture was diluted with EtOAc, washed successively with sat. aq. NaCl, 1 N aq. HCl, sat. aq. NaCl, 10% aq. Na 2 CO 3 , and sat. aq. NaCl, dried over MgSO 4 , and evaporated in vacuo to give crude product, which was purified by silica gel column chromatography (eluent; CHCl 3 , and DMF (25 ml) at Ϫ12°C. The mixture was stirred at Ϫ3°C for 6 h and then at 0°C for 15 h. Then the reaction mixture was poured into ice water (200 ml) and insoluble material was collected by filtration. The residue was washed successively with 1 N aq. HCl, water, 5% aq. NaHCO 3 , and water, after which it was dried over P 2 O 5 under reduced pressure to give 45 as a colorless solid (1.01 g, 90%). mp 236-238°C, Rf 2 0.69. 40 (1H, m), 6.68-6.78 (2H, m), 6.97-7.12 (2H, m) Nagai et al. 32) In a microtube, 20 ml of proMMP-1 [15 U/ml in an assay buffer [50 mM Tris-HCl (pH 7.5), 0.2 M NaCl, 5 mM CaCl 2 ] containing 0.02% BSA] was mixed with 20 ml of 2 mM 4-aminophenylmercuric acetate (APMA) in assay buffer. Then the mixture was incubated at 35°C for 2 h to activate the proenzyme. A 20 ml aliquot of inhibitor (at various concentrations) plus 40 ml of assay buffer were added to the mixture and further incubation was done for 15 min at 35°C. In the case of thiol componds, to ensure that the inhibitor was not oxidised, 1ϫ10
Ϫ4 M b-mercaptoethanol was added to the assay buffer. Then 100 ml of 0.05% FITC-labeled collagen in assay buffer was added, followed by incubation at 35°C for 2 h, after which the reaction was terminated by adding 10 ml of 80 mM o-phenanthroline in 50% ethanol solution. A 200 ml of aliquot of elastase (25 mg/ml assay buffer) was added and the mixture was incubated for 10 min at 35°C to digest the cleaved FITC-labeled collagen fragments. Next, 400 ml of 70% ethanol in 0.17 M Tris-HCl (pH 9.5)/0.67 M NaCl was added and the mixture was vortexed for 30 s, followed by centrifugation for 20 min at 3000 rpm to obtain the supernatant. The fluoresence intensity of this supernatant was measured (l ex 495 nm, l em 520 nm) and the inhibitory activity was calculated as a percentage of the control activity in the absence of any inhibitor.
